Considering that immune cells are an important component of the tumour environment, glioma‐derived exosomes would deliver CT62, DPY19L2P1, and KCNH1‐IT1 to immune cells, regulating the tumour immune microenvironment.59, 60. The gene discussed is DPY19L2P1; the disease is central nervous system cancer.